Immunic, Inc. Reports Year End 2021 Financial Results and Highlights Recent Activity
/PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused...
Source: prnewswire.com